Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate—PYRAMAX®) to standard intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnant women living in endemic areas: ULTRAPYRAPREG

Peer Review reports

Original Submission
7 Jul 2022	Submitted	Original manuscript
4 Aug 2022	Reviewed	Reviewer Report - Riaz Qureshi
1 Sep 2022	Author responded	Author comments - Vivi Maketa Tevuzula
Resubmission - Version 2
1 Sep 2022	Submitted	Manuscript version 2
8 Sep 2022	Reviewed	Reviewer Report - Riaz Qureshi
3 Oct 2022	Author responded	Author comments - Vivi Maketa Tevuzula
Resubmission - Version 3
3 Oct 2022	Submitted	Manuscript version 3
17 Oct 2022	Reviewed	Reviewer Report - Riaz Qureshi
22 Oct 2022	Author responded	Author comments - Vivi Maketa Tevuzula
Resubmission - Version 4
22 Oct 2022	Submitted	Manuscript version 4
Publishing
3 Nov 2022	Editorially accepted
28 Nov 2022	Article published	10.1186/s13063-022-06884-8

Back to article page